KCNK3 and pulmonary arterial hypertension: Otherwise, we recently found that Kcnk3 deficiency in rats (CRISPR/Cas9 technology) leads to higher susceptibility to monocrotaline- or chronic hypoxia-induced PH, confirming that KCNK3 loss of function predisposes one to the development of PAH.